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Galanin (1-15) [GAL(1-15)] participates in mood regulation and depression. GAL(1-
15) is also able to enhance the antidepressant effects induced by Fluoxetine (FLX) in 
the forced swimming test through interaction between GALR1-GALR2 and 5-HT1A 
receptors that induced changes in the binding characteristics and mRNA of the 5-
HT1AR in the hippocampus. 
Since the medial prefrontal cortex (mPFC) is a core region for the interaction 
between emotional processing and cognition with a high density of 5-HT1AR and 
GALR1 and GALR2, we have analyzed the binding characteristics and mRNA levels 
of 5-HT1AR in the mPFC after GAL(1-15)-FLX administration in the rats. GAL(1-15) 
increased the Kd and the Bmax of the 5HT1AR agonist binding in the mPFC as well 
as the mRNA levels of 5-HT1AR in mPFC. Moreover, GAL(1-15) reversed the effects 
of memory impairment induced by FLX(10mg/Kg) in the Novel Object Recognition 
task. GALR2 was involved in these effects, since the specific GALR2 antagonist 
M871 blocked GAL(1-15) mediated actions at behavioral level. On the contrary 
GAL(1-15) did not reverse the effect of FLX in the Object Location Memory task.  
In conclusion, our results describe an interactions between GAL(1-15) and FLX in 
the mPFC involving interactions at the 5-HT1AR receptor level in the plasma 
membrane with changes at the transcriptional level with implications also at 
functional level. The GALR1-GALR2-5-HT1A heteroreceptor could be postulated to 
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Galanin (1-15) [GAL(1-15)] participates in mood regulation and depression. 
GAL(1-15) is also able to enhance the antidepressant effects induced by 
Fluoxetine (FLX) in the forced swimming test through interaction between 
GALR1-GALR2 and 5-HT1A receptors that induced changes in the binding 
characteristics and mRNA of the 5-HT1AR in the hippocampus. 
Since the medial prefrontal cortex (mPFC) is a core region for the interaction 
between emotional processing and cognition with a high density of 5-HT1AR 
and GALR1 and GALR2, we have analyzed the binding characteristics and 
mRNA levels of 5-HT1AR in the mPFC after GAL(1-15)-FLX administration in 
the rats. GAL(1-15) increased the Kd and the Bmax of the 5HT1AR agonist 
binding in the mPFC as well as the mRNA levels of 5-HT1AR in mPFC. 
Moreover, GAL(1-15) reversed the effects of memory impairment induced by 
FLX(10mg/Kg) in the Novel Object Recognition task. GALR2 was involved in 
these effects, since the specific GALR2 antagonist M871 blocked GAL(1-15) 
mediated actions at behavioral level. On the contrary GAL(1-15) did not reverse 
the effect of FLX in the Object Location Memory task.  
In conclusion, our results describe an interactions between GAL(1-15) and FLX 
in the mPFC involving interactions at the 5-HT1AR receptor level in the plasma 
membrane with changes at the transcriptional level with implications also at 
functional level. The GALR1-GALR2-5-HT1A heteroreceptor could be 














Galanin (GAL) is a neuropeptide (Tatemoto et al., 1983) widely distributed in 
neurons within the Central Nervous System (CNS) (Jacobowitz et al., 2004). 
Three GAL receptor (GALR1-3 receptors) subtypes with high affinity for GAL 
have been cloned (Branchek et al., 2000; Mitsukawa et al., 2008). GALR1 and 
GALR2 receptors are found in many regions of the CNS as demonstrated with 
in situ hybridization, radioligand binding and immunohistochemical studies 
(Jacobowitz et al., 2004). GALR1 and GALR3 mainly activate inhibitory G 
proteins Gi/Go, while GALR2 mainly couples to Gq/G11 to mediate excitatory 
signaling (Branchek et al., 2000; Wang et al., 1997). 
 
These three GALR are involved in a number of central functions modulating 
neuroendocrine, pain control, cardiovascular, addiction and food intake (Diaz- 
Cabiale et al., 2010; Mitsukawa et al., 2008; Picciotto, 2010) GAL also 
participates in mood regulation and depression (Bellido et al., 2002; Juhasz et 
al., 2014; Weiss et al., 1998). The activation of GALR1 and GALR3 results in a 
depression like behavior while stimulation of GALR2 leads to anti-depressant-
like effects (Bartfai et al., 2004; Kuteeva et al., 2008; Lu et al., 2005). Moreover, 
GAL modulates 5-HT1A receptor (5-HT1AR) function at autoreceptor and 
postsynaptic level in the brain (Fuxe et al., 1988; Hedlund and Fuxe, 1996; Kehr 
et al., 2002; Misane et al., 1998; Razani et al., 2000; Razani et al., 2001). 
Recent results indicate that this interaction could be in part due to the existence 
of GALR1-5-HT1AR heteroreceptor complexes in discrete brain regions 
(Borroto-Escuela et al., 2010; Fuxe et al., 2012). It has been suggested that in 
depression, the GALR1-5-HT1AR heteroreceptor complexes is dysfunctional 
which may lead to disturbances in meso-limbic 5-HT neurotransmission 
(Borroto-Escuela et al., 2017; Borroto-Escuela et al., 2018).  
 
Not only GAL but also the N-terminal fragments like GAL(1-15) are active in the 
central nervous system (CNS) (Diaz-Cabiale et al., 2007; Diaz-Cabiale et al., 
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2010; Diaz-Cabiale et al., 2005; Flores-Burgess et al., 2017; Millon et al., 2017; 
Millon et al., 2016; Millon et al., 2015). Recently we described that GAL(1-15) 
induces strong depression-related and anxiogenic-like effects in rats and these 
effects were significantly stronger than the ones induced by GAL (Millon et al., 
2015). The receptor for GAL(1-15) is the GALR1-GALR2 isoreceptor dimer 
(Borroto-Escuela et al., 2014; Millon et al., 2015) for which GAL(1-15) has a 
high affinity. The strong depression-like and anxiogenic-like effects of GAL(1-
15) disappeared in the siRNA GALR1 and siRNA GALR2 receptor knockdown 
rats (Millon et al., 2015) and were related to the disappearance of the in situ 
PLA signals and, thus, to the disappearance of the GALR1-GALR2 isoreceptor 
complexes (Millon et al., 2015). 
 
GAL(1-15) is also able to enhance the antidepressant effects induced by the 5- 
HT1AR agonist 8-OH-DPAT in the forced swimming test (FST) (Millon et al., 
2016), effect that was again significantly stronger than the ones induced by 
GAL. Importantly, the mechanism underlying this action involved interactions at 
the receptor level in the plasma membrane with changes also at the 
transcriptional level. GAL(1-15) increased the Kd and Bmax values and the 
mRNA levels of the postjunctional 5-HT1AR in the dorsal hippocampus but not 
of the 5-HT1A autoreceptors in the DR (Millon et al., 2016). The 5-HT1A 
autoreceptor complexes appear to be differentially regulated since a reduction 
of mRNA levels in the DR was observed. The putative existence of a trimeric 
GALR1-GALR2-5-HT1AR heteroreceptor complex was therefore postulated 
which can help explain this interesting enhancement by GAL(1-15) of the 
antidepressant effects of 8-OH-DPAT (Borroto-Escuela et al., 2018; Millon et al., 
2016) and underlie as a mechanism of action independent from GAL.  
 
In line with these results, GAL(1-15) and not GAL enhanced the antidepressant 
effects of the SSRI fluoxetine (FLX) using the FST (Flores-Burgess et al., 2017). 
In the combined treatment with GAL(1-15) and FLX, the modulation of the 5- 
HT1AR agonist binding sites in the dentate gyrus was also different from the 
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modulation found with GAL(1-15). The modulation by combined treatment with 
FLX and GAL(1-15) produced an increased affinity of the 5-HT1AR agonist 
binding sites and a reduction of their Bmax values in the dentate gyrus (Flores- 
Burgess et al., 2017), in contrast to the reduced affinity and increased Bmax 
levels found in this region with GAL(1-15) (Millon et al., 2016). However, the 
increase in 5-HT1AR mRNA levels in the hippocampus was still obtained after 
the combined treatment with GAL(1-15) and FLX, as found after treatment with 
GAL(1-15) alone (Flores-Burgess et al., 2017). 
 
These results illustrate that GAL(1-15) can produce differential changes in 
mood from depressive to antidepressant actions, being dependent on how the 
GALR come together with the 5-HT1AR. The molecular complexes are likely 
highly dynamic and vary from one brain region to another. 
 
The serotonergic system is also implicated in the neurobiological control of 
learning and memory (Meneses, 2007). One of the serotoninergic receptors 
more extensively studied in behavioural learning paradigms is the 5-HT1AR 
(Meneses et al., 2007; Ogren et al., 2008). For example, in the Novel Object 
Recognition task, the systemic administration of the 5-HT1AR specific agonist 
8-OH-DPAT in rats impaired the recognition of the new object, and the 
antagonist WAY100635 blocked these deficits (Meneses et al., 2007; Pitsikas et 
al., 2003). 
 
The role of medial prefrontal cortex (mPFC) in single-item recognition 
memory is not fully dilucidated. Initial studies showed that large 
aspiration lesions of the mPFC produced delay dependent impairments in 
delayed non-matching to sample tasks (Ragozzino et al., 2002; Warburton 
and Brown, 2015), suggesting an involvement for mPFC in this process 
(Morici et al., 2015), but excitotoxic lesion studies indicate that the mPFC 
is not involved in the NOR task based on single-item recognition memory. 
(Warburton and Brown, 2015). However, other studies using more 
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functional approaches, based mainly in the activation of immediate early 
genes (IEGs), have showed that the mPFC increases the expression of c-
Fos (Rinaldi et al., 2010; Castilla-Ortega et al., 2012) and Zif-268 (Freitas 
Barbosa et al., 2013) in response to the test phase in a NOR task, 
supporting that this region is involved at least in the retrieval of this 
recognition memory 
 
Since the mPFC has been recently identified as a core region for the interaction 
between emotional processing and cognition (Ray and Zald, 2012) with a 
particular a high density of 5-HT1AR and GALR1 and GALR2 (Jacobowitz et al., 
2004; Pompeiano et al., 1992, 1994), we have analyzed the binding 
characteristics and mRNA levels of 5-HT1AR in the mPFC after GAL(1-15)-FLX 
administration. Moreover, we have studied the effect of GAL(1-15) on FLX-
mediated behavioural responses using two memory tasks where FLX effect has 
been previously described (Ampuero et al., 2013; Castane et al., 2015), the 
Novel Object Recognition (NOR) and the Object Location Memory (OLM). In 
both tasks FLX treatment did not affect learning or short-term memory but 
specifically impaired long-term memories since animals did not explore 
the new objects in the test session performed 24 h post-training either in 
the OLM or in the NOR tasks (Ampuero et al., 2013; Castane et al., 2015). 
In addition, we tested the involvement of GALR2 in the GAL(1-15) effect with 
the selective GALR2 antagonist M871. 
 
2. Material and Methods 
 
2.1. Animals 
Male Sprague Dawley rats (body weight 225–250g) were obtained from 
CRIFFA, Barcelona and maintained in a 12h dark/light cycle under controlled 
conditions of humidity (55-60%) and temperature (22±2ºC). The animals had 
free access to food pellets and tap water. Behavioral tests were performed 
during the light phase of the cycle. All Experimental procedures were approved 
Flores-Burgess et al., 2019      Neuropharmacology 
 
 7 
by the Institutional Animal Ethics Committee of the University of Málaga, Spain. 
 
2.2. Stereotaxic surgery 
This protocol has been described previously (Diaz-Cabiale et al., 2011). Briefly, 
the rats were anesthetized intraperitoneally with equitesin (3.3ml/kg body 
weight). A chronic 22-gauge stainless-steel guide cannula was stereotaxically 
implanted into the right lateral cerebral ventricle (+1.4mm lateral, -1mm 
posterior to bregma, and 3.6mm below the surface of the skull) (Paxinos, 1986). 
Animals were individually housed after surgery and had a recovery period of 7 
days prior to behavioural test. 
 
2.3. Administration of substances and drugs 
In the experimental groups we used the following drugs: Fluoxetine 
hydrochloride (Sigma-Aldrich, San Luis, EEUU) and GAL(1-15) and the GALR2 
antagonist M871 (TOCRIS, Bristol, Reino Unido). Intracerebroventricular (icv) 
administration of substances was performed for one minute in a volume of 5μl 
using a 26-gauge stainless-steel injection cannula connected to a Hamilton 
siringe via PE-10 tubing with special care that during the process the 
dilutions were administered fluently and without overflowing. All rats that 
received the i.c.v. injections were assumed to have proper cannula 
placement and none were excluded. The solutions were prepared using 
artificial cerebrospinal fluid (aCSF). For subcutaneous (sc) administration of 
Fluoxetine (FLX), solutions was prepared using distillate water for improving the 
solubility in a volume of 2ml/Kg (Lopez-Rubalcava and Lucki, 2000). 
 
2.4. Double Immunofluorescence 
The procedures have been previously used (Millon et al., 2015). Primary 
antibody rabbit anti-GAL2 receptor (Alomone Lab, 1/250) was incubated for 12 
hours at 4ºC and detected with the red secondary antibody mouse anti-rabbit 
DyLight 549 (Jackson inmunoResearch Laboratories, 1/100). Goat anti-GAL1 
receptor (Santa Cruz Biotechnology INC, EEUU, 1:250) was incubated 12 hours 
Flores-Burgess et al., 2019      Neuropharmacology 
 
 8 
at 4ºC and detected with the secondary antibody rabbit biotynilated anti-goat 
(Vector Labs Inc.) and Alexa Fluor 488-conjugated Streptavidin (Jackson 
Laboratories InmunoResearch, 1:1000). Sections were mounted on slides with 
fluorescent mounting medium (Dako) and visualized using a Leica SP8 confocal 
microscope. The double immunolabeling was performed in the tissue of rats 
without treatment. 
 
2.5. Autoradiography and in situ hybridization histochemistry 
The procedure to perform receptor autoradiography and in situ hybridization 
histochemistry was previously described (Flores-Burgess et al., 2017; Millon et 
al., 2016; Saenz del Burgo et al., 2013). 6 rats per group received three sc 
injections of FLX or vehicle at 23, 5 and 1.25 h prior to the sacrifice, and GAL(1- 
15) or aCSF was administered by a single injection via icv 30 minutes before 
sacrifice. In these experiments we have used groups of animals that did 
not perform object recognition tasks. We have used the doses and 
injection schedule based on our previous work where we observed that 
the coadministration of FLX and GAL(1-15) modified the binding 
characteristics and mRNA expression of 5-HT1AR in the dentate gyrus 
(Flores-Burgess et al., 2017; Millon et al., 2016; Millon et al., 2015).  
The pattern of FLX injection was shown to produce effects in the FST similar to 
those obtained after chronic treatment and to those leading to its clinical effects 
in humans (Detke et al., 1997; Estrada-Camarena et al., 2003; Estrada- 
Camarena et al., 2006). Their brains were rapidly removed and frozen in -40°C 
isopenthane and stored at -80ºC until its use. Coronal sections (14μm thick) 
were cut in a cryostate at bregma levels, according to the atlas of (Paxinos, 
1986) (medial prefrontal cortex (mPFC): 3.50mm to 2.70mm), thaw-mounted on 
gelatin-coated slides stored at -20°C until further processing. 
 
2.5.1. Quantitative autoradiography 
Saturation experiments were performed using [3H]-8-OH-DPAT (specific 
activity: 142Ci/mmol, Perkin Elmer, Walthman, Massachusetts) in 
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concentrations ranging from 0.24 to 10.8 nM. In each saturation experiment, 
two groups of ten sections were prepared in order to perform the total binding 
and the non-specific binding. Nonspecific binding was defined as the binding of 
[3H]-8-OH-DPAT in the presence of 10-5M of 5-HT (Sigma Aldrich, St. Louis, 
CA). The brain sections were preincubated for 30 minutes at room temperature 
in 50mM Tris-HCl buffer (pH 7.6), containing 4mM CaCl2, 0.01% ascorbic acid 
and 10mM pargyline. The sections were then incubated for 60 minutes at room 
temperature with [3H]-8-OH-DPAT in the same solution as above. Thereafter, 
the sections were washed twice for 5 minutes in ice cold buffer and rinsed 
briefly in ice-cold destilled water before being dried under a stream of cold air. 
Dried sections were exposed to [3H]- Kodak Biomax-MR (Sigma Aldrich, St. 
Louis, CA) for 6 weeks along with [3H]-radiolabeled standards plastic strips 
(Amersham, UK). 
 
2.5.2. In situ hybridization histochemistry 
For in situ hybridization studies, frozen tissue sections were air-dried at room 
temperature and fixed in 4% paraformaldehyde during 20 minutes and washed 
in phosphate-buffered saline (PBS 1X: 8mM Na2HPO4, 1.4mM KH2PO4, 
136mM NaCl, 2.6mM KCl) for 5 min in 3X PBS at room temperature and twice 
for 5 min each in 1X PBS, then were incubated in a freshly prepared solution of 
predigested pronase (Calbiochem, San Diego, USA) at a final concentration of 
24U/ml in 50mM Tris–HCl, pH 7.5, 5mM EDTA. The enzymatic activity was 
stopped by immersion for 30s in 2mg/mL glycine in 1X PBS. Tissues were 
finally rinsed in 1X PBS and dehydrated through a graded series of ethanol. 
The oligonucleotides used were complementary to the following base 
sequences and were custom-synthesized by Isogen Bioscience (Maarsden, The 
Netherlands): 5HT1A, 1-48, 763-810 and 1219-1266 [Gen Bank acc. No 
NM_012585.1]. The oligonucleotides were labeled at their 3′-end by using 
[33P]dATP (3000Ci/mmol) and terminal deoxynucleotidyl-transferase (TdT, 
Oncogene Research Products, San Diego, CA, USA), and purified using 
MicroSpin G-50 columns (Amersham, UK). For hybridization, 
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radioactivelylabeled probes were diluted to a final concentration of 206cpm/mL 
in a solution containing 50% formamide, 4X SSC (1X SSC: 150mM NaCl, 
15mM sodium citrate), 1X Denhardt's solution (0.02% Ficoll, 0.02% 
polyvinylpyrrolidone, 0.02% bovine serum albumin), 10% dextran sulfate, 1% 
sarkosyl, 20mM phosphate buffer pH 7.0, 250μg/mL yeast tRNA and 500μg/mL 
salmon sperm DNA. Tissues were covered with 80μL of the hybridization 
solution and overlaid with Nescofilm (Bando Chemical Inc., Kobe, Japan) 
coverslips to prevent evaporation. Sections were incubated in humid boxes 
overnight at 42ºC and then washed 4 times (45min each) in 600mM NaCl, 
10mM Tris–HCl, pH 7.5, 1mM EDTA at 60ºC and once in the same buffer at 
room temperature for 30 min. Hybridized sections were exposed to Kodak 
BIOMAX-MR film (Sigma Aldrich, St. Louis, CA) for 10 days at –70ºC with 
intensifying screens. 
 
2.5.3. Image analysis 
Measurements using the ImageJ system (NIH, USA) were made in the distinctly 
labelled region in the mPFC using a square as a sampling field (0.3 mm2). One 
observation per region and rat was obtained, since the average of the 
measurements was calculated. [3H]-radiolabeled standards plastic strips 
(Amersham, UK) were used to convert the grey values into fmol/mg protein 
values in the receptor binding quantitative autoradiography. The 
semiquantitative evaluations of the in situ hybridization autoradiograms were 
performed based on the optical density (O.D.). 
 
2.6. Object Location Memory (OLM) and Novel Object Recognition (NOR) task 
OLM and NOR were performed in an open field test apparatus (100x100 cm) 
under dim light. The task procedures consist of three phases: habituation, 
training, and test (Ampuero et al., 2013) (Fig. 1). The animals were handled 2 
days before the habituation phase. In the habituation phase, animals were 
allowed to explore the open field 10 minutes. 24 h later, in the test phase, two 
identical objects (two plastic boats 20cm high and filled with water) were placed 
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in two opposite corners of the apparatus 10 cm from the side wall and the 
animals were allowed to explore during 3 minutes. The day after we performed 
the test phase. For the NOR task we change one object to other differently 
shaped and colored, the objects were of similar in weight and size (Fig 1A). In 
the OLM we use the same objects employed in the training phase changing the 
location of one of them (Fig 1B). Animals were allowed to explore 3 minutes in 
the test phase. Exploration was defined as sniffing or touching the object with 
the nose and/or forepaws. Turning around or sitting on the object was not 
considered as exploratory behavior. The time spent by the rats exploring each 
object, familiar (F) or new (N), in the test phase was recorded by a video 
camera and was analyzed blind to the treatment. A discrimination index (DI) 
was calculated as: DI=(N-F)/(N+F), this ratio represent the difference in 
exploration time expressed as a proportion of the total time spent exploring the 
two objects (Ennaceur and Delacour, 1988). We also analyzed the locomotor 
activity using the video-tracking software EthovisionXT (Noldus, Wageningen, 
Nederland). Between trials, the role of familiar or new object and the relative 
position were counterbalanced and randomly permuted also the open field and 
the objects were cleaned thoroughly in every phase (Akirav and Maroun, 2006; 
Ampuero et al., 2013). The pharmacological treatments were administered 
between the training and test phases. 
 
2.6.1. Behavioural assessment 
Different groups of rats were assessed in the NOR and OLM. In the first set of 
experiment in order to evaluate the interaction of FLX with GAL(1-15) in the 
NOR task, groups of rats received before the test phase three injections (23, 5 
and 1 h) of sc FLX(10mg/kg) or vehicle and a single icv injection of a threshold 
dose of GAL(1-15)(1nmol) or aCSF 15 minutes before the test. We also 
determined the involvement of GALR2 in the effect of GAL(1-15) on 
FLXmediated action in rats that received three injections of sc FLX(10mg/kg), a 
single icv injection of GAL(1-15)(1nmol) and the GALR2 antagonist M871 
(3nmol) icv in combination. In the second set of experiments we evaluate the 
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interaction of FLX with GAL(1-15) in the OLM task, groups of rats received three 
injections of FLX(10mg/Kg) alone or in combination with GAL(1-15)(1nmol).  
 
2.7. Statistical analysis 
Data are presented as the mean ± SEM and samples number (n) are indicated 
in figure legends. All data were analyzed using GraphPad PRISM 6.0 
(GraphPad Software, La Jolla, CA). One-way analysis of variance (ANOVA) 
followed by Newman-Keuls comparison post hoc-test was performed. 
Differences were considered significant at p<0.05 (*p<0.05, **p<0.01, 
***p<0.001). The data from the saturation experiments were analyzed by 
nonlinear regression analysis for the determination of the dissociation constant 





3.1. Neurochemical effects 
3.1.2. 5-HT1AR agonist radioligand binding. Saturation curves. 
An extensive colocalization of GALR1 and GALR2 immunoreactivities was 
observed in the nerve cells of the mPFC (Fig. 2). 
 
In the autoradiographic experiments, the coadministration of the three injections 
of sc FLX(10mg/kg) and a single icv injection of GAL(1-15)(1nmol) produced a 
significant increase in the Kd value (Fig. 3A; F3,20=14.36, p<0.001; post hoc 
p<0.01) and in the Bmax value (Fig. 3B; F3,18=5.57, p<0.01; post hoc p<0.05) of 
the agonist radioligand [3H]-8-OH-DPAT compared with FLX(10mg/Kg) in the 
mPFC. Representative autoradiograms with a low radioligand concentration 
(1nM) illustrate the decrease of labelling (increase in Kd values) in the mPFC 
30min after the coadministration of the three injections of sc FLX(10mg/kg) and 
a single icv injection of GAL(1-15)(1nmol) (Fig. 3C). 
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3.1.3. 5-HT1AR mRNA levels 
In the In situ hybridization experiments, the coadministration of the three sc 
injections of FLX(10mg/kg) and a single icv injection of GAL(1-15)(1nmol) 
produced a significant increase in the 5-HT1AR mRNA levels in the mPFC (Fig. 
4A; F3,19=6.418, p<0.01; post hoc p<0.01) compared with FLX(10mg/Kg) group. 
Representative autoradiograms illustrate the increase of 5-HT1AR mRNA levels 
in the mPFC, after the coadministration of the three sc injections of FLX 
(10mg/kg) and a single icv injection of GAL(1-15)(1nmol) (Fig. 4B). 
 
3.2. Behavioral effects 
3.2.1. NOR 
The overall one way ANOVA revealed a significant effect between treatments in 
DI in the NOR task (Fig. 5; F3,18=6.393, p<0.01). 
The coadministration of the three sc injections of FLX(10mg/kg) and a single icv 
injection of GAL(1-15)(1nmol) reversed the effects of memory impairment 
induced by FLX(10mg/Kg) alone (Fig. 5; post hoc p<0.05) in the NOR showing 
the same DI values as the control group. 
 
In agreement with other studies where FLX induces an impairment memory 
effects in the NOR when tested at 24h post training phase (Ampuero et al., 
2013; Castane et al., 2015), our pattern of administration of FLX with three 
injections given sc at 10mg/kg between the training and test phase also induced 
the same effects in this task (Fig. 5; post hoc p<0.05). 
 
In the same experiment we tested the involvement of the GALR2 in the GAL(1-
15)-FLX(10mg/kg) interaction with the selective GALR2 antagonist M871. 
M871(3nmol) blocked the effects of GAL(1-15) over FLX in the NOR task since 
the coadministration of the three sc injections of FLX(10mg/kg) and a single icv 
injection of GAL(1-15)(1nmol) in combination with M871(3nmol) induced a 
significant reduction of the DI (Fig. 5; post hoc p<0.05) compared with the group 
of animals treated with FLX(10mg/Kg) plus GAL(1-15)(1nmol). 




No pharmacological treatment used in the NOR task in this experiment 
significantly modified the analyzed parameters of locomotor activity (Table1A; 
F2,14=0.19; p=0.828) and the total time of exploration (Table1A; F2,14=2.19; 
p=0.148) in the test phase.  
In the training phase, the total object exploration time confirmed that there 
was no difference in the baseline exploration levels between the groups 
(Table 2). 
 
The administration of a single icv injection of GAL(1-15)(1nmol) or M871(3nmol) 
alone did not modified any parameter analyzed in the NOR task: DI (Table 1B; 
F2,18=0.097; p=0.907), locomotor activity (Table 1B; F2,18=0.144; p=0.866), total 
time of exploration (Table 1B; F2,18=0.67; p=0.524). 
 
3.2.2. OLM 
The coadministration of the three sc injections of FLX(10mg/kg) and a single icv 
injection of GAL(1-15)(1nmol) in this task potenciate FLX-action in the DI 
although it did not reach the statistical significance, indicating an opposite effect 
of GAL(1-15) than in the NOR task. 
 
The sc administration of three injections of FLX(10mg/Kg) between the training 
and test phase in the OLM task showed a reduction in the DI compared with the 
control group although it didn’t reach the significance (Fig. 6; F2,15=3.24, 
p=0.0675). 
 
No pharmacological treatment used in the OLM task significantly modified the 
analyzed parameters of locomotor activity (Table1; F2,15=2.03; p=0.165) and the 
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In the present work we described for the first time the interactions between 
GAL(1-15) and FLX in the mPFC involving interactions at the 5-HT1AR level in 
the plasma membrane with changes also at the transcriptional level. Thus, the 
coadministration of GAL(1-15) and FLX increased the Kd and the Bmax of the 
5HT1AR agonist binding in the mPFC as well as the mRNA levels of 5-HT1AR 
in mPFC. Moreover, GAL(1-15) reversed the effects of memory impairment 
induced by FLX(10mg/Kg) in the Novel Object Recognition. GALR2 was 
involved in these effects, since the specific GALR2 antagonist M871 blocked 
GAL(1-15) mediated actions at behavioral level. On the contrary GAL(1-15) did 
not reverse the effect of FLX in the Object Location Memory. 
 
We have described previously an interaction between GAL(1-15) and FLX; 
GAL(1-15) enhanced the antidepressant effects of FLX in the forced swim test 
(Flores-Burgess et al., 2017). The mechanism of this effect was explained on 
the bases of the existence of a trimeric GALR1-GALR2-5-HT1AR 
heteroreceptor complex (Borroto-Escuela et al., 2018; Flores-Burgess et al., 
2017; Millon et al., 2016) since an increase in the mRNA levels of postjunctional 
5-HT1AR in the dorsal hippocampus and a decrease in Kd and Bmax values, 
specifically in the dentate gyrus of the hippocampus was observed (Flores- 
Burgess et al., 2017). Such heteroreceptor complexes could work as integrative 
nodes in 5-HT neurotransmission and as major targets for the antidepressant 
effects of GAL(1-15)+FLX at postjunctional level of 5-HT transmission of the 
raphe-hippocampal neurons (Fuxe et al., 2012; Fuxe et al., 2008; Millon et al., 
2016). 
 
Our results in the present paper suggest that the molecular complexes GALR1- 
GALR2-5-HT1A are likely highly dynamic and vary from one brain region to 
another. In fact, GAL(1-15)+FLX administration induced the opposite effect 
in the modulation of 5-HT1AR in the mPFC compared to the dentate gyrus 
(Flores-Burgess et al., 2017), however the increase in 5-HT1AR mRN A levels 
in the mPFC was still obtained after the GAL(1-15)+FLX administration. It´s 
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interesting to highlight that the administration of FLX or GAL(1-15) alone did not 
change the Kd or the Bmax of 5-HT1AR neither the mRNA levels in the mPFC. 
This results are in agreement with our previous work (Li et al., 1997; Flores-
Burgess et al., 2017) and suggest that GAL(1-15) and FLX interact at 
membrane level in the mPFC to modify this parameters. 
 
The differential effects observed with the combination of GAL(1-15)+FLX in the 
modulation of the 5-HT1AR recognition in the mPFC vs the hippocampus may 
be explained by differences in the composition of the 5-HT1AR heteroreceptor 
complexes involved in the two regions. This can lead to alterations in the 
allosteric receptor-receptor interactions and in the signaling of the 
heteroreceptor complexes. Also the adapter proteins in the heterocomplexes 
may differ between the two regions with consequences for the allosteric 
receptor-receptor interactions. It has also been described regional differences in 
the coupling of 5-HT1AR to G protein. 5-HT1AR interact equally with GD0 and 
GDi3 in the cerebral cortex but mainly with GDo and weakly with GDi3 in the 
hippocampus (Mannoury la Cour et al., 2006). Such differences may contribute 
to the opposite effect in the affinity and Bmax of the 5-HT1AR binding sites in 
the mPFC in contrast to the hippocampus (Borroto-Escuela et al., 2018; Flores- 
Burgess et al., 2017). 
 
Since FLX induced increases in extracellular levels of 5-HT likely increasing 5- 
HT signaling not only over the 5-HT1AR receptor, but also over a number of 
other 5-HT receptor subtypes, the participation of other 5-HT receptor subtypes 
with high density in the mPFC such as 5-HT2A (Castane et al., 2015) in the 
interaction remains to be tested. 
 
At behavioural level, the interaction between GAL(1-15)+FLX was 
demonstrated in the NOR task. The NOR task was developed to provide a valid 
measure of memory function based upon spontaneous exploratory activity in 
the rat (Ennaceur et al., 1997). Object recognition can be assessed form the 
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preference normal rats display for investigating novel rather than familiar 
complex objects having been characterized as declarative rather than non-
declarative memory task (Ennaceur et al., 1997). 
 
The role of mPFC in single-item recognition memory is not fully 
dilucidated. Initial studies showed that large aspiration lesions of the 
mPFC produced delay dependent impairments in delayed non-matching to 
sample tasks (Ragozzino et al., 2002; Warburton and Brown, 2015), 
suggesting an involvement for mPFC in this process (Morici et al., 2015), 
but excitotoxic lesion studies indicate that the mPFC is not involved in the 
NOR task based on single-item recognition memory. (Warburton and 
Brown, 2015). However, other studies using more functional approaches, 
based mainly in the activation of immediate early genes (IEGs), have 
showed that the mPFC increases the expression of c-Fos (Rinaldi et al., 
2010; Castilla-Ortega et al., 2012) and Zif-268 (Freitas Barbosa et al., 2013) 
in response to the test phase in a NOR task, supporting that this region is 
involved at least in the retrieval of this recognition memory. Moreover, 
other studies using intra-mPFC infusions of D1, D2 and D3 agonists and 
antagonist, were able to affect the long-term memory consolidation in a 
NOR task (Papp et al., 2017). All these results suggest that mPFC is 
involved in single-item recognition memory (NOR), and that its main role 
seems to be associated with both, memory retrieval and long-term 
memory consolidation (Frankland and Botempi 2005; Leon et al., 2010). 
 
With the experimental design used in our study, where FLX was 
administered 23, 5 and 1 h and GAL(1-15) 15 min before memory retrieval 
phase in the NOR, it is clear that GAL(1-15) was able to counteract the 
impairment induced by FLX in this task, affecting the retrieval of a 
consolidated memory. In addition, this effect cannot be explained by the 
modulation of other memory phases as the acquisition or the retention. 
Interestingly, several results based in the use of IEGs, support the 
Flores-Burgess et al., 2019      Neuropharmacology 
 
 18 
involvement of the mPFC in the retrieval phase in this task (Rinaldi et al., 
2010; Castilla-Ortega et al., 2012; Freitas Barbosa et al., 2013), suggesting 
that likely GAL(1-15) is acting through the mPFC in order to modulates 
memory retrieval. 
 
The fact that GAL(1-15) reversed the effects of memory impairment induced by 
FLX(10mg/Kg) in the NOR task could be associated with the proposed trimeric 
GALR1-GALR2-5-HT1AR heteroreceptor in the mPFC. Since GAL(1-15) acts 
through a GALR1-GALR2 heteroreceptor complexes that inhibits the Gq/G11- 
mediated signaling of the GALR2 protomer and switches it towards Gi/o-
mediated signaling enhancing Gi/o-mediated signaling of GALR1 in the GALR1-
GALR2 heterodimer (Borroto-Escuela et al., 2014; Millon et al., 2015), the 
mechanism for the GALR1-GALR2-5-HT1AR heteroreceptor complex in the 
mPFC could be explain on the bases that this enhancement of Gi/o-mediated 
signal will impair 5-HT1AR receptor signaling in the trimer complex explaining 
that the coadministration of GAL(1-15)+FLX reversed FLX-mediated effects. 
GALR2 is involved in the GAL(1-15) effects since the GALR2 antagonist M871 
blocked the effects induced by GAL(1-15) on FLX-mediated effects.  
 
FLX induces an impairment memory effects in the NOR when tested at 24h post 
training phase (Ampuero et al., 2013; Castane et al., 2015), without any effect 
in the spontaneous motor behaviours (Ampuero et al., 2013). Our results with 
FLX are in agreement with these studies and confirm our pattern of 
administration of FLX and the behavioural model used. 
 
On the contrary GAL(1-15) did not reverse the effect of FLX in the OLM 
task. In this task the rats are presented with two identical, familiar objects, one 
of which is in its previous location while the other is in a new location. Normal 
rats spontaneously spend more time exploring the object in the novel location 
(Ennaceur et al., 1997). The OLM task assess spatial memory in a less aversive 
manner than in the Morris water maze task (Akirav and Maroun, 2006; Ampuero 
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et al., 2013). 
 
Since the hippocampus is crucial in spatial memory tasks such as the OLM task 
(Barker and Warburton, 2011), the fact that GAL(1-15) did not reverse FLX 
action in the OLM task, its in agreement with previous results from our group 
that demonstrate that the GALR1-GALR2-5-HT1AR heteroreceptor in the 
hippocampus enhances 5-HT1AR receptor signaling in the complex by, inter 
alia, reducing 5-HT1AR internalization from the plasma membrane (Borroto-
Escuela et al., 2018; Flores-Burgess et al., 2017). 
 
Although several authors described the key role of the mPFC in the associative 
learning tasks based on the natural exploration as the NOR (Muller and Knigh, 
2006; Meneses 2007) and the hippocampus as a crucial region in the OLM task 
(Barker and Warburton, 2011), we can no exclude the influence of other brain 
areas related to the regulation of both emotional and cognitive behaviors 
(Ampuero et al., 2013; Meneses 2007). 
 
In conclusion, our results describes an interactions between GAL(1-15) and 
FLX in the mPFC involving interactions at the 5-HT1AR level in the plasma 
membrane with changes also at the transcriptional level and these interactions 
may be associated with the effects at functional level, since GAL(1-15) 
reversed the effects of memory impairment induced by FLX in the Novel Object 
Recognition. The target for GAL(1-15) may mainly be GALR1-GALR2-5-HT1AR 
heteroreceptor and confirmed that these molecular complexes are likely highly 
dynamic and vary from one brain region to another and can be used to reverse 
some of the adverse effects of FLX on memory processes.  
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Figure 1: Schematic representation of the procedures followed to perform the 
behavioural experiments in the NOR (A) and OLM (B). In both tasks animals 
had a recovery period of 7 days prior to behavioural test and the animals 
performed the tasks in three phases, separated 24 hours from each other, 
where they explore freely during 10min in the habituation phase without objects, 
3min in the training phase with two identical objects and finally 3min in the test 
phase with one object changed in the NOR or one object in other location 
respect the training phase in the OLM. The pharmacological treatments were 
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administered to the different groups of animals between the training and testing 
phases. 
 
Figure 2: Representative microphotography of the colocalization of GALR1 and 
GALR2 in neurons of the mPFC. Double-immunolabeled for GALR1 (green, 
rhombus) and GALR2 (red, arrowhead) in mPFC. The colocalization of GALR1 
and GALR2 is shown in the merge (orange-yellow, arrows). Escale bar, 50 μm.  
 
Figure 3: Effects on the binding characteristics of 5-HT1AR agonist [3H]-8 
OHDPAT in the mPFC after the coadministration of FLX(10mg/kg) or GAL(1- 
15)(1nmol) alone or in combination. FLX was administered sc 23, 5 and 1,25h 
before sacrifice and GAL(1-15) or aCSF was injected icv 30min before. 
Saturation experiments were performed with ten concentrations of [3H]-8-
OHDPAT (0.26-10nM) in sections from the mPFC. Non-specific binding was 
defined as the binding in the presence of 10mM serotonin. The Kd (A) and the 
Bmax (B) values are shown as mean ± SEM (n=6 per group). In the control 
group the Kd(nM) value was 0.6±0.04 and Bmax(fmol/mg prot) was 654±15. 
*p<0.05, **p<0.01, ***p<0.01 versus FLX(10mg/Kg)+GAL(1-15)(1nmol) group 
and ##p<0.01, ###p<0.001 versus control group according to one way ANOVA 
followed by Newman-Keuls Multiple Comparison Test. (C) Representative 
autoradiograms from mPFC sections of rat showing a decrease of the affinity of 
the agonist for 5-HT1AR in the mPFC with a low concentration of the 
radioligand (1nM). 
 
Figure 4: Effects of the coadministration of FLX(10mg/kg) and GAL(1-15) 
(1nmol) on 5-HT1AR mRNA levels in the mPFC. FLX was administered sc 23, 5 
and 1,25h before sacrifice and GAL(1-15) or aCSF was injected icv 30min 
before. (A) The values of optical density (O.D.), mean ± SEM (n=6 per group), 
are expressed as percentages respect of the control values (100%). **p<0.01 
versus FLX(10mg/Kg)+GAL(1-15)(1nmol) group and ##p<0.01 versus control 
group according to one way ANOVA followed by Newman-Keuls Multiple 
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Comparison Test. (B) Representative autoradiograms from mPFC showing the 
levels of mRNA coding for 5-HT1AR determined by in situ hybridization and the 
analyzed areas. 
 
Figure 5: Graphic shows the ability of rats to discriminate the novel object at 
24h post-training after the administration of FLX(10mg/kg) alone or in 
combination with a threshold doses of GAL(1-15)(1nmol) or GAL(1-15) plus the 
GALR2 antagonist M871(3nmol) in the NOR task. FLX or vehicle was 
administered sc 23, 5 and 1h before the test. aCSF, GAL(1-15) and GAL(1- 
15)+M871 were injected icv 15 min before the test. Data represents mean ± 
SEM of the DI during the 3 min of the test phase (n=5-6 rats per group). 
*p<0.05 versus FLX(10mg/Kg)+GAL(1-15)(1nmol) group and #p<0.01 versus 
control group according to one way ANOVA followed by Newman-Keuls Multiple 
Comparison Test. 
 
Figure 6: Graphic shows the ability of rats to discriminate the relocated object 
at 24h post-training after the administration of FLX(10mg/kg) alone or in 
combination with a threshold doses of GAL(1-15)(1nmol) in the OLM task. FLX 
or vehicle was administered sc 23, 5 and 1h before the test. aCSF, GAL(1-15) 
were injected icv 15min before the test. Data represents mean ± SEM of the DI 
during the 3 min of the test phase (n=6 rats per group). No statistically 
significant difference was observed between the experimental groups according 
to one way ANOVA followed by Newman-Keuls Multiple Comparison Test. 
 
Table 1: Table shows A) the locomotor activity and total exploration time of the 
rats in the NOR and OLM tasks after the administration of FLX(10mg/kg) alone 
or in combination with a threshold dose of GAL(1-15)(1nmol) or GAL(1-
15)(1nmol)+M871(3nmol) during the test phase. FLX or vehicle was 
administered sc 23, 5 and 1h before the test. aCSF or GAL(1-15) were injected 
icv 15min before the test. B) Discrimination index, locomotor activity and total 
exploration time of the rats in the NOR tasks after the administration of GAL(1-
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15)(1nmol) or M871(3nmol) alone during the test phase. Vehicle was 
administered sc 23, 5 and 1h before the test. aCSF, GAL(1- 15) or M871 were 
injected icv 15 min before the test. No statistically significant difference was 
observed vs control group according to one way ANOVA followed by 
Bonferroni´s Multiple Comparison Test. 
 
Table 2: Total object exploration time by groups in the training phase of the 
NOR and OLM tasks before the administration of the treatments. No statistically 
significant difference was observed between the experimental groups according 
to one way ANOVA followed by Newman-Keuls Multiple Comparison Test. 
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